Never Too Old? Age Should Not Be a Barrier to Enrollment in Cancer Clinical Trials

Never Too Old? Age Should Not Be a Barrier to Enrollment in Cancer Clinical Trials Matti S. Aapro, Claus-Henning Köhne, Harvey Jay Cohen, Martine Extermann Oncologist 2005; 10: 198-204 Author Information and Disclosures Target Audience: Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Discuss the implications of age bias in clinical trials. Describe the effects of applying clinical trial advances to the elderly as predicted by the available information. Explain the need for designing and implementing clinical trials that include the elderly. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Mar. 25, 2005 Most Recent Review: Mar. 25, 2005* Most Recent Update: Mar. 25, 2005 Date Credit Expires: Apr. 12, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.